Related Experiment Video

Updated: Jul 11, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Prostate cancer: a dynamic illness with shifting targets

David R Shaffer1, Howard I Scher

  • 1Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

The Lancet. Oncology
|July 10, 2003
PubMed

Insights

Androgen ablation for advanced prostate cancer is not curative due to resistant cells. Targeted therapies must address prostate cancer

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Medicine

Background:

  • Androgen ablation therapy (AAT) shows high response rates but fails to cure advanced prostate cancer.
  • The emergence of androgen-independent, resistant prostate cancer cells limits AAT efficacy.
  • New targeted therapies aim to overcome resistance by inhibiting key growth and survival pathways.

Purpose of the Study:

  • To emphasize the dynamic nature of prostate cancer evolution.
  • To highlight the need for targeted therapies that address disease progression.
  • To improve clinical outcomes by accounting for dynamic molecular determinants of sensitivity and resistance.

Main Methods:

  • Review of current understanding of prostate cancer progression and resistance mechanisms.
  • Analysis of emerging targeted therapy strategies.
  • Conceptual framework for dynamic treatment approaches.

Main Results:

  • Prostate cancer is a dynamic disease that evolves during progression.
  • Molecular determinants of sensitivity and resistance are state-specific.
  • Current targeted therapies require a dynamic approach for maximum efficacy.

Conclusions:

  • Effective eradication of resistant prostate cancer requires understanding its dynamic evolution.
  • Targeted therapies must be tailored to specific disease states and molecular determinants.
  • A dynamic, adaptive treatment strategy is crucial for improving clinical outcomes in advanced prostate cancer.

More Related Videos

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...